"Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma"
— J. Proteome Res. 2022, 21, 1083−1094, Peer-Reviewed Article
"Clinicians' Perspective on Use of Immune Checkpoint Inhibitors and Related Biomarkers for Solid Tumors"
— British Journal of Cancer Research 2022;5(1): 550 – 557, Peer-Reviewed Article
"Serum glycoproteomic signatures predict overall survival in bone and soft tissue sarcoma patients treated with immune checkpoint inhibitor therapy"
— American Society of Clinical Oncology (ASCO) 2022, Poster
"Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint-inhibitor treatment benefit in metastatic malignant melanoma"
— American Society of Clinical Oncology (ASCO) 2022, Poster
"Liquid-biopsy-derived Glycoproteomic Profiling as a Novel Means for Noninvasive Diagnosis of Ovarian Cancer."
— American Society of Clinical Oncology (ASCO) 2022, Online Abstract
"Glycoproteomics as a powerful liquid biopsy-based screening tool for non-small cell lung cancer."
— American Society of Clinical Oncology (ASCO) 2022, Online Abstract
"Clinicians’ perspective on use of immune checkpoint inhibitors and related biomarkers for solid tumors."
— American Society of Clinical Oncology (ASCO) 2022, Online Abstract
"Identifying potential glycoproteomic biomarkers for diagnosis of colorectal cancer."
— American Society of Clinical Oncology (ASCO) 2022, Online Abstract
"Predicting breast cancer in women using liquid biopsy-derived glycoproteomic markers."
— American Society of Clinical Oncology (ASCO) 2022, Online Abstract
"Peripheral Blood Glycoproteomic Biomarkers As A Powerful New Tool For The Detection Of Nasopharyngeal Carcinoma"
— Association for Cancer Research (AACR) 2022 , Abstract
"Glycoproteomics-based Liquid Biopsy Informs Optimal Checkpoint-inhibitor Drug Choice"
— Association for Cancer Research (AACR) 2022 , Abstract
"Novel Plasma Glycoprotein Biomarkers Predict Progression-Free Survival In Surgically Resected Clear Cell Renal Cell Carcinoma"
— Urologic Oncology: Seminars and Original Investigations
"30 Blood-Based Glycoprotein Signatures In Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Receiving First-Line Immune Checkpoint Blockade"
— BMJ Publishing Group Ltd
"Differential Glycoprotein Profiles In Severe And Asymptomatic COVID-19"
— American Society for Mass Spectrometry, 2021
"Glycoproteomics As A Powerful Liquid Biopsy-Based Predictor Of Checkpoint-Inhibitor Treatment Response"
— American Association for Cancer Research
"Site-Specific Glycosylation Quantitation Of 50 Serum Glycoproteins Enhanced By Predictive Glycopeptidomics For Improved Disease Biomarker Discovery"
— Analytical Chemistry, 2019
"Serum Glycoproteomic-Based Liquid Biopsy For The Detection Of Pancreatic Ductal Adenocarcinoma."
— Journal of Clinical Oncology
